Join Professor John Camm for his discussion on Atrial Fibrillation.
BBC Breakfast News
Patients and network staff talk about their experiences of being involved in clinical research.
Atrial Fibrillation Antiarrhythmic Drugs.
Professor John Camm discusses the two newest antiarrhythmic drugs dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away.
Watch us work.
Now's your chance to watch us work - check out the video below for a snapshot of our bustling team in action.
What 20 years of clinical research has taught us about our industry and the future of drug development
June 9, 2021
As Richmond Pharmacology approaches its 20th anniversary our co-founder and CEO reflects on the developments, regulatory changes, and innovations within the life science industry in an article in the PharmaTimes.
Nir Eyal and colleagues suggested that the initiation of COVID-19 challenge trials in response to the UK governments’ call in 2020 remained relevant and important despite the development of approved vaccines and the introduction of an aggressive, UK-wide vaccination policy.
Novel rate-controlled fentanyl patch shows promise in phase I clinical trial
April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.